Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients

被引:1
作者
Yan, Liping [1 ]
Shen, Hongbo [1 ]
Xiao, Heping [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept TB, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
来源
BMC INFECTIOUS DISEASES | 2018年 / 18卷
关键词
Pulmonary tuberculosis; V gamma 2V delta 2 T cells; Interferon-gamma release assays; T-SPOT.TB; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; INFECTION; DIAGNOSIS; RESPONSES; ACTIVATION; CHILDREN; IMMUNITY; SYSTEM; ANERGY;
D O I
10.1186/s12879-018-3328-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: It is not fully explained why some active tuberculosis patients show negative interferon-gamma release assays (IGRAs). In this study, we tried to explore associations of IGRAs with the characteristics of peripheral V gamma 2V delta 2 T cells and their functions of producing cytokines. Methods: 32 pulmonary tuberculosis patients were enrolled and divided into two groups according to their IGRAs results: 16 with IGRA-negative as test group and 16 with IGRA-positive as control group. Chest X-rays and T-SPOT. TB tests were performed and the severity of the lung lesions was scored. The amount of V gamma 2V delta 2T cell and their expression levels of the apoptosis-related membrane surface molecule Fas and FasL in peripheral blood were analyzed by flow cytometry, and the function of secreting cytokines (IFN-gamma, TNF-alpha and IL-17A) of V gamma 2V delta 2 T cell were determined by intracellular cytokine staining. Results: The IGRA-negative TB patients had more lesion severity scores and displayed reduced peripheral blood V gamma 2V delta 2 T cell counts (p = 0.009) as well as higher Fas and FasL expression in peripheral blood V gamma 2V delta 2 T cells (p = 0. 043, 0.026). A high lesion severity score was correlated with a decreased V delta 2+ T cell number and increased V gamma 2V delta 2 T cells Fas/FasL expression leve in the peripheral blood (p = 0.00, P < 0.01). The function of secreting cytokines was slightly impaired in IGRA-negative TB patients (p = 0.402). There is no significant differences in expression levels of Fas and FasL in CD4+ T cells (p = 0.224, 0.287) or CD8+ T cells (p = 0.184, 0.067) between test and control groups. Conclusion: Compared with IGRA-positive TB patients, the IGRA-negative TB patients had more lesion severity scores, the number of V gamma 2V delta 2 T cells decreased and the function of secreting cytokines impaired. In addition, we suggest that increased expression of Fas/FasL triggers V gamma 2V delta 2 T cell apoptosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
    Cimini, Eleonora
    Bonnafous, Cecile
    Bordoni, Veronica
    Lalle, Eleonora
    Sicard, Helene
    Sacchi, Alessandra
    Berno, Giulia
    Gioia, Cristiana
    D'Offizi, Gianpiero
    Comandini, Ubaldo Visco
    Vlassi, Chrysoula
    Capobianchi, Maria Rosaria
    Martini, Federico
    Agrati, Chiara
    PLOS ONE, 2012, 7 (05):
  • [22] Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications
    Li, Haishan
    Chaudry, Suchita
    Poonia, Bhawna
    Shao, Yiming
    Pauza, C. David
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (01) : 42 - 49
  • [23] An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients
    El Daker, Sary
    Sacchi, Alessandra
    Montesano, Carla
    Altieri, Alfonso Maria
    Galluccio, Giovanni
    Colizzi, Vittorio
    Martini, Federico
    Martino, Angelo
    CELLULAR IMMUNOLOGY, 2013, 282 (02) : 106 - 112
  • [24] Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behcet's disease
    Wu, Xiuhua
    Chen, Pang
    Wei, Wei
    Zhou, Mengyu
    Li, Chaoran
    Liu, Jinjing
    Zhao, Lidan
    Zhang, Lifan
    Zhao, Yan
    Zeng, Xiaofeng
    Liu, Xiaoqing
    Zheng, Wenjie
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [25] Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells
    Urban, Elizabeth M.
    Li, Haishan
    Armstrong, Cheryl
    Focaccetti, Chiara
    Cairo, Cristiana
    Pauza, C. David
    BMC IMMUNOLOGY, 2009, 10 : 50
  • [26] Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells
    Okuno, Daisuke
    Sugiura, Yuki
    Sakamoto, Noriho
    Tagod, Mohammed S. O.
    Iwasaki, Masashi
    Noda, Shuto
    Tamura, Akihiro
    Senju, Hiroaki
    Umeyama, Yasuhiro
    Yamaguchi, Hiroyuki
    Suematsu, Makoto
    Morita, Craig T.
    Tanaka, Yoshimasa
    Mukae, Hiroshi
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] High Prevalence of Latent Tuberculosis Infection in Dialysis Patients Using the Interferon-γ Release Assay and Tuberculin Skin Test
    Lee, Susan Shin-Jung
    Chou, Kang-Ju
    Dou, Horng-Yunn
    Huang, Tsi-Shu
    Ni, Yen-Yun
    Fang, Hua-Chang
    Tsai, Hung-Chin
    Sy, Cheng-Len
    Chen, Jui-Kuang
    Wu, Kuang-Sheng
    Wang, Yung-Hsin
    Lin, Hsi-Hsun
    Chen, Yao-Shen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08): : 1451 - 1457
  • [28] Application of interferon-γ release assay in extrapulmonary tuberculosis diagnosis, T-lymphocyte regulation, and efficacy evaluation in Northwest China
    Liu, Zhao
    Zhang, Qi
    Li, Qian
    Wang, Longzhi
    Ren, Leipeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3885 - 3894
  • [29] Cord Blood Vγ2Vδ2 T Cells Provide a Molecular Marker for the Influence of Pregnancy-Associated Malaria on Neonatal Immunity
    Cairo, Cristiana
    Longinaker, Nyaradzo
    Cappelli, Giulia
    Leke, Rose G. F.
    Ondo, Manuel Mve
    Djokam, Rosine
    Fogako, Josephine
    Leke, Robert J.
    Sagnia, Bertrand
    Sosso, Samuel
    Colizzi, Vittorio
    Pauza, C. David
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (10) : 1653 - 1662
  • [30] Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis
    Sauzullo, I.
    Mengoni, F.
    Marocco, R.
    Potenza, C.
    Skroza, N.
    Tieghi, T.
    Lichtner, M.
    Vullo, V.
    Mastroianni, C. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (05) : 1133 - 1140